Contracts › HT942523C0044
HT942523C0044: Medical & Research Development Contract for Dha Sttr Phase Ii A2- 9499 Proposal Titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection"
Awarded to Giner, Inc. by Defense Health Agency.
$1.1Mobligated
$1.1Mpotential value
13 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0044 |
|---|---|
| Awardee | Giner, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MA |
| Offers received | 3 |
| Period of performance | 14 July 2023 to 13 August 2026 |
| Potential end | 13 August 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record